In primary open-angle glaucoma, the TET enzyme maintained the hypomethylation of the GDF7 promoter in trabecular meshwork (TM) cells (Wan et al., 2021), thereby activating the bone morphogenetic protein receptor type 2 and Smad signaling pathways. The gene discussed is GDF7; the disease is glaucoma.